Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
Queensland Health
Moodys
Daiichi Sankyo
Medtronic
Johnson and Johnson
UBS
Argus Health
Cantor Fitzgerald

Generated: December 11, 2017

DrugPatentWatch Database Preview

HYDROPRES 50 Drug Profile

« Back to Dashboard

Which patents cover Hydropres 50, and when can generic versions of Hydropres 50 launch?

Hydropres 50 is a drug marketed by Merck and is included in one NDA.

The generic ingredient in HYDROPRES 50 is hydrochlorothiazide; reserpine. There are thirty-one drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; reserpine profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
MerckHYDROPRES 50hydrochlorothiazide; reserpineTABLET;ORAL011958-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cantor Fitzgerald
Farmers Insurance
Accenture
Fish and Richardson
Novartis
Cipla
Deloitte
Daiichi Sankyo
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot